PFM Health Sciences
Investor profile
Venture capital
PFM Health Sciences has backed 3 European tech companies across 3 funding rounds between 2021 and 2024, joining rounds totalling €930M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2021–2024
4 yrs
Total round €
€930M
sum of rounds joined
Deals by year
distinct rounds / yearPFM Health Sciences — deals by year — interactive chart.
Data table
| PFM Health Sciences — deals by year | |
|---|---|
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Top sectors
by dealsPFM Health Sciences — top sectors — interactive chart.
Data table
| PFM Health Sciences — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsPFM Health Sciences — stages — interactive chart.
Data table
| PFM Health Sciences — stages | |
|---|---|
| Other | 1 |
| Series C | 1 |
| Series D+ | 1 |
Countries
by dealsPFM Health Sciences — countries — interactive chart.
Data table
| PFM Health Sciences — countries | |
|---|---|
| UK | 2 |
| Germany | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Aescuvest1
- Aisling Capital1
- Ally Bridge Group1
- Armistice Capital1
- BIONIQ Capital1
- BlackRock Innovation Capital1
- Cambridge Innovation Capital1
- Chimera Partners1
- Cure Capital1
- GE Healthcare1
- Laurion Capital Management1
- Lauxera Capital Partners1
- LGT1
- Logos Capital1
- MTIP AG1
- Optum Ventures1
- Paradigm BioCapital Advisors1
- Pictet Alternative Advisors1
- Plug & Play Growth Fund1
- ProAssurance Corp1
- RA Capital1
- Relyens Group1
- RPMI Railpen1
- SoftBank Vision Fund 21
- Soleus Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| CMR Surgical | UK | 1 | €505M |
| Compass Pathways | UK | 1 | €261M |
| Caresyntax | Germany | 1 | €164M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| CMR Surgical | Series D+ | €505M | 2021-07 |
| Compass Pathways | Other | €261M | 2023-08 |
| Caresyntax | Series C | €164M | 2024-08 |